Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Parkinson's Disease

Free Subscription Articles published in J Neural Transm Retrieve available abstracts of 79 articles: HTML format Text format

Single Articles

January 2012
1. CHRISTINE CW , Marks WJ Jr, Ostrem JL
   Development of Parkinson's disease in patients with Narcolepsy.
   J Neural Transm. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. STOCHL J , Croudace TJ, Brozova H, Klempir J, et al
   Changes of hand preference in Parkinson's disease.
   J Neural Transm. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. DI BIASIO F , Vanacore N, Fasano A, Modugno N, et al
   Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?
   J Neural Transm. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
4. JELLINGER KA
   CSF biomarkers in different phenotypes of Parkinson disease.
   J Neural Transm. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. DENG Y , Zhang Y, Li Y, Xiao S, et al
   Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains.
   J Neural Transm. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
6. KRAJCOVICOVA L , Mikl M, Marecek R, Rektorova I, et al
   The default mode network integrity in patients with Parkinson's disease is levodopa equivalent dose-dependent.
   J Neural Transm. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PEREIRA EA , Nandi D, Jenkinson N, Stein JF, et al
   Pedunculopontine stimulation from primate to patient.
   J Neural Transm. 2011;118:1453-60.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HAMANI C , Moro E, Lozano AM
   The pedunculopontine nucleus as a target for deep brain stimulation.
   J Neural Transm. 2011;118:1461-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. MAZZONE P , Scarnati E, Garcia-Rill E
   Commentary: the pedunculopontine nucleus: clinical experience, basic questions and future directions.
   J Neural Transm. 2011;118:1391-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. JELLINGER K
    Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. CALIANDRO P , Insola A, Scarnati E, Padua L, et al
    Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. 
    The pedunculopontine nucleus: from basic neuroscience to translational applications for Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
13. PRIKRYLOVA VRANOVA H , Mares J, Hlustik P, Nevrly M, et al
    Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. JENNER P , McCreary AC, Scheller DK
    Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SADOWSKI K , Szlachta K, Serafin-Krol M, Galazka-Friedman J, et al
    Brain tissue echogenicity-implications for substantia nigra studies in parkinsonian patients.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
16. ZADORI D , Klivenyi P, Toldi J, Fulop F, et al
    Kynurenines in Parkinson's disease: therapeutic perspectives.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KORCZYN AD
    Comment: should we diagnose MCI in Parkinson disease?
    J Neural Transm. 2011;118:1177.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
18. BARES M , Rektorova I, Jech R, Farnikova K, et al
    Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. GERLACH M , Maetzler W, Broich K, Hampel H, et al
    Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. DESAI BRADARIC B , Patel A, Schneider JA, Carvey PM, et al
    Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
21. BUGALHO P , Paiva T
    Dream features in the early stages of Parkinson's Disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. YUST-KATZ S , Shitrit D, Melamed E, Djaldetti R, et al
    Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. FERRAYE MU , Debu B, Fraix V, Krack P, et al
    Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MARTINEZ-HORTA S , Kulisevsky J
    Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. REKTOROVA I
    Mild cognitive impairment exists in Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KORCZYN AD
    Editorial comments: treatment of motor fluctuations in Parkinson's disease.
    J Neural Transm. 2011;118:905-6.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
27. WALTER U , Witt R, Wolters A, Wittstock M, et al
    Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. HAKIMI M , Selvanantham T, Swinton E, Padmore RF, et al
    Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.
    J Neural Transm. 2011;118:795-808.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
29. HALLIDAY GM , Song YJ, Harding AJ
    Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. RANSMAYR G
    Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
31. KATSCHNIG P , Schwingenschuh P, Jehna M, Svehlik M, et al
    Altered functional organization of the motor system related to ankle movements in Parkinson's disease: insights from functional MRI.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KIYOHARA C , Miyake Y, Koyanagi M, Fujimoto T, et al
    APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. GILLE G , Reichmann H
    Iron-dependent functions of mitochondria--relation to neurodegeneration.
    J Neural Transm. 2011;118:349-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CRICHTON RR , Dexter DT, Ward RJ
    Brain iron metabolism and its perturbation in neurological diseases.
    J Neural Transm. 2011;118:301-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
35. ALLERT N , Kelm D, Spottke A, Coenen VA, et al
    Role of dysphagia in evaluating Parkinson patients for subthalamic nucleus stimulation: a case report.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MULLER T , Jugel C, Ehret R, Ebersbach G, et al
    Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FERNANDEZ-CORCUERA P , Aguilar S, Vicens V, Mora J, et al
    ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-Ioflupane SPET.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. KEYSER RJ , Oppon E, Carr JA, Bardien S, et al
    Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. OKA H , Toyoda C, Yogo M, Mochio S, et al
    Reduced cardiac (123)I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. PREDIGER RD , Rojas-Mayorquin AE, Aguiar AS Jr, Chevarin C, et al
    Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. INZELBERG R , Rabey JM, Melamed E, Djaldetti R, et al
    High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KIM HJ , Yun JY, Kim JM, Kim YK, et al
    Extranigral extension of structural midbrain lesions overshadows parkinsonism.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
43. GERLACH M , Beck J, Riederer P, van den Buuse M, et al
    Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. GERLACH M , Bartoszyk GD, Riederer P, Dean O, et al
    Role of dopamine D(3) and serotonin 5-HT (1A) receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. LIEPELT-SCARFONE I , Behnke S, Godau J, Schweitzer KJ, et al
    Relation of risk factors and putative premotor markers for Parkinson's disease.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. SRULIJES K , Mallien G, Bauer S, Dietzel E, et al
    In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. BERG D
    Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. HARVEY BK , Richie CT, Hoffer BJ, Airavaara M, et al
    Transgenic animal models of neurodegeneration based on human genetic studies.
    J Neural Transm. 2011;118:27-45.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
49. WALTER U
    Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. HILKER R , Antonini A, Odin P
    What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. DEXTER DT , Statton SA, Whitmore C, Freinbichler W, et al
    Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. HASSIN-BAER S , Cohen OS, Vakil E, Molshazki N, et al
    Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
53. GILADI N , Fichtner A, Poewe W, Boroojerdi B, et al
    Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. GRUNBLATT E , Zehetmayer S, Jacob CP, Muller T, et al
    Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BRAAK H , Thal DR, Del Tredici K
    Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson's disease cases.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. BERG D , Godau J, Riederer P, Gerlach M, et al
    Microglia activation is related to substantia nigra echogenicity.
    J Neural Transm. 2010;117:1287-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
57. CASTELLANI RJ , Nugent SL, Morrison AL, Zhu X, et al
    CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MOREIRA EL , Rial D, Aguiar AS Jr, Figueiredo CP, et al
    Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
59. FERRER I , Martinez A, Blanco R, Dalfo E, et al
    Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. BERG D
    Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
61. DEBS R , Cochen De Cock V, Negre-Pages L, Aristin M, et al
    Thought disorders among non-demented outpatients with Parkinson's disease: prevalence and associated factors.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. WOLZ M , Lohle M, Strecker K, Schwanebeck U, et al
    Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. PRIKRYLOVA VRANOVA H , Mares J, Nevrly M, Stejskal D, et al
    CSF markers of neurodegeneration in Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
64. SALA G , Brighina L, Saracchi E, Fermi S, et al
    Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
65. QIAN L , Flood PM, Hong JS
    Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. STACY M
    The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. LV Z , Jiang H, Xu H, Song N, et al
    Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. MAGUIRE-ZEISS KA , Federoff HJ
    Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. BARDIEN S , Marsberg A, Keyser R, Lombard D, et al
    LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. WULLNER U , Kassubek J, Odin P, Schwarz M, et al
    Transdermal rotigotine for the perioperative management of Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
71. O'SULLIVAN DB , Harrison PT, Sullivan AM
    Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo.
    J Neural Transm. 2010;117:559-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
72. GNANA OLI R , Fazeli G, Kuhn W, Walitza S, et al
    No increased chromosomal damage in L: -DOPA-treated patients with Parkinson's disease: a pilot study.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. MARCELLINO D , Suarez-Boomgaard D, Sanchez-Reina MD, Aguirre JA, et al
    On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. CORNEJO CASTRO EM , Waak J, Weber SS, Fiesel FC, et al
    Parkinson's disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. PIETZARKA K , Reimann M, Schmidt C, Herting B, et al
    The cold hand sign in multiple system atrophy: skin perfusion revisited.
    J Neural Transm. 2010;117:475-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
76. SKODDA S , Flasskamp A, Schlegel U
    Instability of syllable repetition as a model for impaired motor processing: is Parkinson's disease a "rhythm disorder"?
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. BALAS M , Balash Y, Giladi N, Gurevich T, et al
    Cognition in multiple system atrophy: neuropsychological profile and interaction with mood.
    J Neural Transm. 2010;117:369-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
78. BOTHE MR , Uttner I, Otto M
    Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. ALLERT N , Lehrke R, Sturm V, Volkmann J, et al
    Secondary failure after ten years of pallidal neurostimulation in a patient with advanced Parkinson's disease.
    J Neural Transm. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: